Historical shareholding details of T. Rowe Price Health Sciences Fund holdings in NovoCure Ltd (NVCR)

Monthly changes of T. Rowe Price Health Sciences Fund shareholding in NovoCure Ltd over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 T. Rowe Price Health Sciences Fund 333,207 0.30%
Jan 31, 2025 T. Rowe Price Health Sciences Fund 634,591 0.58%
Dec 31, 2024 T. Rowe Price Health Sciences Fund 1,217,920 1.11%
Nov 30, 2024 T. Rowe Price Health Sciences Fund 1,326,838 1.23%
Oct 31, 2024 T. Rowe Price Health Sciences Fund 1,670,566 1.54%
Sep 30, 2024 T. Rowe Price Health Sciences Fund 1,672,332 1.55%
Aug 31, 2024 T. Rowe Price Health Sciences Fund 1,705,684 1.58%
Jun 30, 2024 T. Rowe Price Health Sciences Fund 1,550,229 1.43%
Mar 31, 2024 T. Rowe Price Health Sciences Fund 1,750,715 1.63%
Dec 31, 2023 T. Rowe Price Health Sciences Fund 1,542,682 1.44%
Sep 30, 2023 T. Rowe Price Health Sciences Fund 1,201,190 1.12%
Jun 30, 2023 T. Rowe Price Health Sciences Fund 1,359,137 1.27%
Mar 31, 2023 T. Rowe Price Health Sciences Fund 1,416,658 1.33%

View all ownership details of NovoCure Ltd